Fusarium falciforme keratitis in a corneal transplant recipient treated successfully with fosmanogepix and intracameral amphotericin B
ASM Case Reports · 03.11.2026 · 2 (6)
DOI: 10.1128/asmcr.00033-26 ↗Kurz gefasst
Fallbericht in der Zeitschrift ASM Case Reports, erschienen am 03.11.2026. Verfasst von Ashley Zeoli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Background
Ocular fungal infections are a major cause of vision loss worldwide. Fusarium spp., a leading cause of fungal keratitis, is often difficult to treat. There are no current standardized treatment guidelines for fungal keratitis. We present a case of Fusarium spp. keratitis that was treated with fosmanogepix and intracameral amphotericin B, highlighting additional treatment options in difficult-to-treat cases. To our knowledge, this is the first report of fosmanogepix use in Fusarium keratitis. Case Summary A 72-year-old man presented with 2 weeks of right eye pain and redness and was diagnosed with Fusarium falciforme keratitis via ocular fungal culture. He failed multiple topical, oral, and intraocular antifungal agents, and required corneal transplantation. Histopathology from his explant showed hyaline hyphae with occasional sickle-shaped conidia, consistent with Fusarium spp. The infection recurred in the corneal allograft despite intravitreal voriconazole, intraocular amphotericin B, and topical natamycin. Ultimately, he underwent successful treatment with fosmanogepix, a first-in-class antifungal agent.
Conclusion
Our case illustrates the challenges of managing Fusarium keratitis and the potential role of novel antifungal agents, such as fosmanogepix, as adjuncts to established intraocular and topical therapy in the setting of clinical failure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Ophthalmology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University, Nashville, Tennessee, USA.
- Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: Lili Tao, Breann Zeches, Augusto Dulanto Chiang
Förderung
- NCATS NIH HHS
Zitieren
APA
Zeoli, A., Shieh, C., Bloch, K. C., Tao, L., Mainor, A., Cimino, C., Zeches, B., & Dulanto Chiang, A. (2026). Fusarium falciforme keratitis in a corneal transplant recipient treated successfully with fosmanogepix and intracameral amphotericin B. ASM Case Reports, 2(6). https://doi.org/10.1128/asmcr.00033-26
Vancouver
Zeoli A, Shieh C, Bloch KC, Tao L, Mainor A, Cimino C, et al. Fusarium falciforme keratitis in a corneal transplant recipient treated successfully with fosmanogepix and intracameral amphotericin B. ASM Case Reports. 2026;2(6). doi:10.1128/asmcr.00033-26
BibTeX
@article{Zeoli2026,
author = {Zeoli, Ashley and Shieh, Christine and Bloch, Karen C and Tao, Lili and Mainor, Alex and Cimino, Christo and Zeches, Breann and Dulanto Chiang, Augusto},
title = {Fusarium falciforme keratitis in a corneal transplant recipient treated successfully with fosmanogepix and intracameral amphotericin B},
journal = {ASM Case Reports},
year = {2026},
volume = {2},
number = {6},
doi = {10.1128/asmcr.00033-26}
}
EUVIMED